Valeo Financial Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

Valeo Financial Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$59.18 - $69.99 $38,230 - $45,213	-646 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$59.31 - $78.82 $4,804 - $6,384	-81 Reduced 11.14%	646 $45,000
Q4 2020 Feb 11, 2021	BUY	$50.47 - $66.26 $4,189 - $5,499	83 Added 12.89%	727 $44,000
Q3 2020 Oct 28, 2020	BUY	$51.97 - $63.0 $22,710 - $27,531	437 Added 211.11%	644 $39,000
Q2 2020 Jul 20, 2020	BUY	$30.8 - $52.47 $369 - $629	12 Added 6.15%	207 $11,000
Q3 2019 Oct 15, 2019	BUY	$35.66 - $44.99 $2,282 - $2,879	64 Added 48.85%	195 $7,000
Q2 2019 Jul 10, 2019	BUY	$36.57 - $47.97 $3,657 - $4,797	100 Added 322.58%	131 $6,000
Q4 2018 Jan 30, 2019	SELL	$41.31 - $52.16 $123 - $156	-3 Reduced 8.82%	31 $1,000
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $1,213 - $1,343	34	34 $1,000

264

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $909M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.